COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 249.5 | 3 | 0035-0385 | 203.48 | 384.96 | 224 | 61.70 | 0.739 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 245.3 | 3 | 0036-0396 | 810.66 | 396.52 | 284 | 63.60 | 0.882 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 252.2 | 3 | 0037-0402 | 50.40 | 402.63 | 241 | 60.77 | 0.820 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 268.1 | 3 | 0038-0407 | 742.68 | 408.20 | 266 | 64.18 | 0.811 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 229.1 | 3 | 0039-0408 | 893.26 | 407.85 | 285 | 67.26 | 0.792 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 299.4 | 3 | 0040-0454 | 910.50 | 453.38 | 237 | 58.77 | 0.862 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 239.2 | 3 | 0041-0486 | 783.43 | 486.83 | 257 | 62.18 | 0.835 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 282.3 | 3 | 0042-0489 | 453.81 | 489.03 | 234 | 57.36 | 0.894 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 252.1 | 3 | 0043-0499 | 369.03 | 498.82 | 247 | 60.18 | 0.857 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 236.6 | 3 | 0044-0535 | 663.85 | 535.40 | 257 | 62.87 | 0.817 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 261.6 | 3 | 0045-0539 | 343.31 | 539.41 | 471 | 89.74 | 0.735 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 404.8 | 3 | 0046-0531 | 785.86 | 531.44 | 177 | 51.11 | 0.851 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 485.2 | 3 | 0047-0549 | 945.50 | 548.90 | 266 | 68.63 | 0.710 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 238.7 | 3 | 0048-0558 | 808.51 | 557.74 | 322 | 68.18 | 0.870 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 398.6 | 3 | 0049-0560 | 315.90 | 559.69 | 220 | 93.40 | 0.317 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 234.2 | 3 | 0050-0565 | 444.93 | 564.88 | 283 | 66.18 | 0.812 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 252.6 | 3 | 0051-0575 | 624.95 | 575.22 | 373 | 72.18 | 0.900 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 241.0 | 3 | 0052-0581 | 325.62 | 582.28 | 262 | 61.94 | 0.858 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 227.8 | 3 | 0053-0609 | 835.51 | 610.13 | 302 | 66.18 | 0.866 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 318.4 | 3 | 0054-0645 | 276.97 | 644.96 | 208 | 56.87 | 0.808 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 208.8 | 3 | 0055-0663 | 699.65 | 662.76 | 264 | 65.36 | 0.777 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 251.2 | 3 | 0056-0664 | 832.78 | 663.96 | 216 | 59.84 | 0.758 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 336.0 | 3 | 0057-0666 | 97.42 | 666.26 | 212 | 53.94 | 0.916 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 221.4 | 3 | 0058-0670 | 618.50 | 669.36 | 259 | 66.43 | 0.738 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 250.0 | 4 | 0001-0035 | 57.39 | 34.95 | 202 | 56.77 | 0.788 |